Joy Alamgir is an entrepreneur based in Massachusetts currently pursuing ideas in biotechnology with a computational focus under the umbrella Alamgir Research Inc. Using high-performance computing to perform picometer-scale molecular modeling, his company simulates how key proteins COVID 19 uses to propagate behave in the presence of existing FDA-approved therapies. Viruses replicate by entering cells and commandeering their reproductive machinery. SARS-CoV-2 makes multiple proteins to propagate. If these proteins can be safely and effectively targeted, then viral activity and replication can be inhibited, resulting in reduced disease severity.